Hepatopancreatobiliary Carcinoma — Trials

Hepatopancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,361
Recruiting: 790
Ph III recruiting: 74
Growth YoY: +9.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (646)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01741597	Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung	withdrawn	Phase 1	0	City of Hope Medical CenterOTHER	1	May 30, 2014	clinicaltrials
NCT01618253	Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma	withdrawn	Phase 1	0	Medical College of WisconsinOTHER	1	Sep 5, 2013	clinicaltrials